These compounded drugs are not approved by the FDA, and serious concerns with these drugs have been identified, including dosing errors, unapproved salt forms, and adverse events that have led to hospitalization
WADA 2026 Prohibited List Status (S2.2.3 Growth Hormone Fragments) AOD-9604 is named explicitly on the World Anti-Doping Agency 2026 Prohibited List under section S2.2.3 (Growth hormone, its analogs and fragments), prohibited at all times, both in-competition and out-of-competition
There are several GLP-1 RAs available 4 in the US market, and those reported in this cohort included semaglutide, liraglutide, exenatide, dulaglutide, and tirzepatide
Pre-filled pens have similar in-use storage guidelines, which are specified in the manufacturers instructions
Results: The serum lipidome profile of RA was distinguishable from that of OA and HC